Tissue acquisition and specimen processing in the diagnosis of NSCLC

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 6, 2013, Pages 787-791

  Akulian, Jason ^a   Yarmus, Lonny ^b   Feller Kopman, David ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

endobronchial ultrasound (EBUS); epidermal growth factor receptor (EGFR); lung cancer; lymph node; mediastinal staging; non small cell lung cancer (NSCLC)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BRONCHOSCOPE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER STAGING; CHROMOSOME REARRANGEMENT; DIAGNOSTIC VALUE; ENDOBRONCHIAL ULTRASONOGRAPHY; ENDOBRONCHIAL ULTRASOUND GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED BIOPSY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MEDIASTINOSCOPY; ONCOGENE K RAS; PAPANICOLAOU TEST; PRIORITY JOURNAL; TISSUE SECTION; TRANSBRONCHIAL ASPIRATION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; HUMANS; LUNG NEOPLASMS; MEDIASTINOSCOPY; NEOPLASM STAGING; SPECIMEN HANDLING; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 84888348378     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1358555     Document Type: Article

References (42)

1. American Cancer Society Cancer Facts & Figures 2013. Atlanta American Cancer Society: 2013
2. Johnson D. H., Fehrenbacher L., Novotny W. F., et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol: 2004; 22 11 2184 2191 (Pubitemid 41095154)
3. Sandler A., Gray R., Perry M. C., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med: 2006; 355 24 2542 2550 (Pubitemid 44917502)
4. Scagliotti G., Brodowicz T., Shepherd F. A., et al. Treatment-by- histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J Thorac Oncol: 2011; 6 1 64 70
5. Tsuta K., Tanabe Y., Yoshida A., et al. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol: 2011; 6 7 1190 1199
6. Navani N., Brown J. M., Nankivell M., et al. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med: 2012; 185 12 1316 1322
7. Travis W. D., Brambilla E., Noguchi M., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol: 2011; 6 2 244 285
8. Coudert B., Ciuleanu T., Park K., et al. SATURN Investigators. Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy. Ann Oncol: 2012; 23 2 388 394
9. Mitsudomi T., Morita S., Yatabe Y., et al. West Japan Oncology Group. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol: 2010; 11 2 121 128
10. Mok T. S., Wu Y. L., Thongprasert S., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med: 2009; 361 10 947 957
11. Koivunen J. P., Mermel C., Zejnullahu K., et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res: 2008; 14 13 4275 4283
12. Silvestri G. A., Gould M. K., Margolis M. L., et al. American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest: 2007; 132 (3, Suppl): 178S 201S (Pubitemid 47502807)
13. Detterbeck F. C., Jantz M. A., Wallace M., Vansteenkiste J., Silvestri G. A.; American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest: 2007; 132 (3, Suppl): 202S 220S (Pubitemid 47502808)
14. Erasmus J. J., Sabloff B. SCT. CT, positron emission tomography, and MRI in staging lung cancer. Clin Chest Med: 2008; 29 1 39 57, v (Pubitemid 351220909)
15. Medford A. R., Bennett J. A., Free C. M., Agrawal S. Mediastinal staging procedures in lung cancer: EBUS, TBNA and mediastinoscopy. Curr Opin Pulm Med: 2009; 15 4 334 342
16. Gilbert C., Yarmus L., Feller-Kopman D. Use of endobronchial ultrasound and endoscopic ultrasound to stage the mediastinum in early-stage lung cancer. J Natl Compr Canc Netw: 2012; 10 10 1277 1282
17. Casal R. F., Staerkel G. A., Ost D., et al. Randomized clinical trial of endobronchial ultrasound needle biopsy with and without aspiration. Chest: 2012; 142 3 568 573
18. Eapen G. A., Shah A. M., Lei X., et al. American College of Chest Physicians Quality Improvement Registry, Education. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry. Chest: 2013; 143 4 1044 1053
19. Herth F. J. Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med: 2011; 32 1 62 68
20. Silvestri G. A., Gonzalez A. V., Jantz M. A., et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest: 2013; 143 (5, Suppl): e211S e250S
21. van Eijk R., Licht J., Schrumpf M., et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS ONE: 2011; 6 3 e17791
22. Billah S., Stewart J., Staerkel G., Chen S., Gong Y., Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol: 2011; 119 2 111 117
23. Nakajima T., Yasufuku K., Suzuki M., et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest: 2007; 132 2 597 602 (Pubitemid 47282394)
24. Schuurbiers O. C., Looijen-Salamon M. G., Ligtenberg M. J., van der Heijden H. F. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol: 2010; 5 10 1664 1667
25. Sakairi Y., Nakajima T., Yasufuku K., et al. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res: 2010; 16 20 4938 4945
26. Tanner N. T., Watson P., Boylan A., et al. Utilizing endobronchial ultrasound with fine-needle aspiration to obtain tissue for molecular analysis: a single-center experience. J Bronchology Interv Pulmonol: 2011; 18 4 317 321
27. Diacon A. H., Koegelenberg C. F., Schubert P., et al. Rapid on-site evaluation of transbronchial aspirates: randomised comparison of two methods. Eur Respir J: 2010; 35 6 1216 1220
28. Lee H. S., Lee G. K., Lee H. S., et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest: 2008; 134 2 368 374
29. Paez J. G., Jänne P. A., Lee J. C., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science: 2004; 304 5676 1497 1500 (Pubitemid 38720929)
30. Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A: 2004; 101 36 13306 13311 (Pubitemid 39209661)
31. Lynch T. J., Bell D. W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med: 2004; 350 21 2129 2139 (Pubitemid 38637993)
32. Nakajima T., Yasufuku K., Nakagawara A., Kimura H., Yoshino I. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest: 2011; 140 5 1319 1324
33. Trisolini R., Cancellieri A., Tinelli C., et al. Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy: a randomized trial. Chest: 2011; 139 2 395 401
34. Yarmus L., Van der Kloot T., Lechtzin N., Napier M., Dressel D., Feller-Kopman D. A randomized prospective trial of the utility of rapid on-site evaluation of transbronchial needle aspirate specimens. J Bronchology Interv Pulmonol: 2011; 18 2 121 127
35. Feller-Kopman D., Yung R. C., Burroughs F., Li Q. K. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer: 2009; 117 6 482 490
36. Yarmus L. B., Akulian J., Lechtzin N., et al. American College of Chest Physicians Quality Improvement Registry, Education, and Evaluation (AQuIRE) Participants. Comparison of 21-gauge and 22-gauge aspiration needle in endobronchial ultrasound-guided transbronchial needle aspiration: results of the American College of Chest Physicians Quality Improvement Registry, Education, and Evaluation Registry. Chest: 2013; 143 4 1036 1043
37. Nakajima T., Yasufuku K., Takahashi R., et al. Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration. Respirology: 2011; 16 1 90 94
38. Yung R. C., Otell S., Illei P., et al. Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration. Cancer Cytopathol: 2012; 120 3 185 195
39. Yasufuku K., Chiyo M., Sekine Y., et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest: 2004; 126 1 122 128 (Pubitemid 38943127)
40. Yu H. A., Arcila M. E., Rekhtman N., et al. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res: 2013; 19 8 2240 2247
41. Vincent M. D., Kuruvilla M. S., Leighl N. B., Kamel-Reid S. Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS. Curr Oncol: 2012; 19 01 S33 S44
42. Lindeman N. I., Cagle P. T., Beasley M. B., et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol: 2013; 8 7 823 859